Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab

被引：0
|
作者：
Chaudhary, Varun [1 ]
Brent, Michael [2 ]
Lam, Wai-Ching [2 ]
Devenyi, Robert [2 ]
Teichman, Joshua [1 ]
Mak, Michael Ying-Kit [2 ]
Kaur, Harneel [1 ]
Barbosa, Joshua [1 ]
Carter, Ronald [4 ]
Farrokhyar, Forough [3 ]
机构：
[1] McMaster Univ, Hamilton Reg Eye Inst, Dept Surg, Div Ophthalmol, Hamilton, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[3] McMaster Univ, Dept Surg, Hamilton, ON, Canada
[4] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
来源：
OPHTHALMOLOGICA | 2018年 / 239卷 / 04期
关键词：
D O I：
10.1159/000481178
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [21] Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration
    Piermarocchi, Stefano
    Miotto, Stefania
    Colavito, Davide
    Leon, Alberta
    Segato, Tatiana
    ACTA OPHTHALMOLOGICA, 2015, 93 (06) : E451 - E457
  • [22] Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
    Suzuki, Misa
    Nagai, Norihiro
    Izumi-Nagai, Kanako
    Shinoda, Hajime
    Koto, Takashi
    Uchida, Atsuro
    Mochimaru, Hiroshi
    Yuki, Kenya
    Sasaki, Mariko
    Tsubota, Kazuo
    Ozawa, Yoko
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (09) : 1186 - 1191
  • [23] Ranibizumab for Age-Related Macular Degeneration
    Trempe, Clement
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 581 - 582
  • [24] The Treatment of Wet Age-Related Macular Degeneration
    Joussen, Antonia M.
    Bornfeld, Norbert
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (18): : 312 - +
  • [25] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [26] Ranibizumab for Age-related Macular Degeneration
    Seider, Michael I.
    Stewart, Jay M.
    OPHTHALMOLOGY, 2011, 118 (08) : 1693 - 1694
  • [27] Quality of Life of Patients with Wet Age-Related Macular Degeneration Under Treatment with Ranibizumab
    Charonis, Alexandros
    Datseris, Ioannis
    Androudi, Sophia
    Lake, Symeon
    Tranos, Paris
    Asteriadis, Solon
    Kousidou, Olga
    Pantelopoulou, Georgia
    OPHTHALMOLOGICA, 2014, 232 : 9 - 9
  • [28] Ranibizumab for age-related macular degeneration
    Dhoot, Dilsher S.
    Kaiser, Peter K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (03) : 371 - 381
  • [29] Efficiency of Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
    Sahin, Didem
    Sahin, Ahmet
    Aksoy, Adnan
    Aslan, Lokman
    Simsek, Ali
    CUKUROVA MEDICAL JOURNAL, 2015, 40 (04): : 757 - 765
  • [30] A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
    Lores-Motta, Laura
    van Asten, Freekje
    Muether, Philipp S.
    Smailhodzic, Dzenita
    Groenewoud, Joannes M.
    Omar, Amer
    Chen, John
    Koenekoop, Robert K.
    Fauser, Sascha
    Hoyng, Carel B.
    den Hollander, Anneke I.
    de Jong, Eiko K.
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (01): : 20 - 27
12345